Market Research Report
Biosimilar Commercial Strategies and Tactics
|Published by||Datamonitor Healthcare||Product code||911301|
|Published||Content info||67 Pages
Delivery time: 1-2 business days
|Biosimilar Commercial Strategies and Tactics|
|Published: May 14, 2019||Content info: 67 Pages||
The challenges faced by biosimilar developers are not unlike those confronting their branded counterparts. First, companies must develop high-quality biosimilars and obtain regulatory approval. Next, they must then navigate the vast array of commercial nuances that exist at the national level in order for their products to be used in the clinical setting.